Li B et al. |
Expression of OPG, RANKL, and RUNX2 in rabbit periodontium under orthodontic force. |
2015 |
Genet. Mol. Res. |
pmid:26782591
|
Rewiuk K and Grodzicki T |
Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation. |
2015 |
Biomed Res Int |
pmid:26504794
|
Pesce Viglietti AI et al. |
Brucella abortus Invasion of Osteocytes Modulates Connexin 43 and Integrin Expression and Induces Osteoclastogenesis via Receptor Activator of NF-κB Ligand and Tumor Necrosis Factor Alpha Secretion. |
2015 |
Infect. Immun. |
pmid:26459511
|
Pitari MR et al. |
Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts. |
2015 |
Oncotarget |
pmid:26160841
|
Hsu BG et al. |
High Serum Osteoprotegerin Is Associated with Arterial Stiffness in Kidney Transplant Patients. |
2015 |
Tohoku J. Exp. Med. |
pmid:26156285
|
Miao X et al. |
Nanosecond pulsed electric field inhibits proliferation and induces apoptosis in human osteosarcoma. |
2015 |
J Orthop Surg Res |
pmid:26148858
|
Shen Y et al. |
(5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway. |
2015 |
BMC Complement Altern Med |
pmid:25887296
|
Duan P et al. |
Gene polymorphisms in RANKL/RANK/OPG pathway are associated with ages at menarche and natural menopause in Chinese women. |
2015 |
BMC Womens Health |
pmid:25884698
|
Oostra DR et al. |
Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. |
2015 |
Mol. Cell. Endocrinol. |
pmid:25575458
|
Majerczyk M et al. |
[Osteoprotegerin as a marker of atherosclerosis and a prognostic factor in stroke]. |
2015 |
Postepy Hig Med Dosw (Online) |
pmid:27259222
|